Spiro Rombotis
2010
In 2010, Spiro Rombotis earned a total compensation of $660.4K as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 5% increase compared to previous year.
Compensation breakdown
| Bonus | $59,500 |
|---|---|
| Option Awards | $92,250 |
| Salary | $476,100 |
| Other | $32,506 |
| Total | $660,356 |
Rombotis received $476.1K in salary, accounting for 72% of the total pay in 2010.
Rombotis also received $59.5K in bonus, $92.3K in option awards and $32.5K in other compensation.
Rankings
In 2010, Spiro Rombotis' compensation ranked 6,740th out of 10,439 executives tracked by ExecPay. In other words, Rombotis earned more than 35.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,740 out of 10,439 | 35th |
Division Manufacturing | 2,455 out of 3,838 | 36th |
Major group Chemicals And Allied Products | 569 out of 926 | 39th |
Industry group Drugs | 372 out of 685 | 46th |
Industry Pharmaceutical Preparations | 279 out of 481 | 42nd |
Source: SEC filing on April 19, 2012.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2010.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020